Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Mr. Kevin J. BuehlerIndependent Chairman | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 49,14k | 74,63% |
| 2026-05-20 | Dr. Stanley R. FrankelIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 40,48k | 107,81% |
| 2026-05-20 | Ms. Melinda BrownIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 44,35k | 89,95% |
| 2026-05-20 | Ms. Shari Lisa PireIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 35,03k | 149,70% |
| 2026-05-20 | Mr. Geno J. GermanoIndependent Director | 21,00k | 0,00 | Derivative Exercise and Retained Stock | - | 44,88k | 87,93% |
| 2026-02-17 | Mr. Dario ScimecaGeneral Counsel & Secretary | -4,93k | 18,91k | Derivative Exercise and Sale | 3,84 | 56,46k | - |
| 2026-02-17 | Mr. Michael AmorosoPresident, CEO & Director | 47,24k | 0,00 | Derivative Exercise and Retained Stock | - | 243,39k | 24,08% |
| 2026-02-17 | Mr. Michael AmorosoPresident, CEO & Director | -20,56k | 78,95k | Derivative Exercise and Sale | 3,84 | 243,39k | - |
| 2026-02-17 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | 11,74k | 0,00 | Derivative Exercise and Retained Stock | - | 129,86k | 9,94% |
| 2026-02-17 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | -4,93k | 18,91k | Derivative Exercise and Sale | 3,84 | 129,86k | - |
| 2026-02-17 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 19,44k | 0,00 | Derivative Exercise and Retained Stock | - | 125,88k | 18,26% |
| 2026-02-17 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -8,15k | 31,29k | Derivative Exercise and Sale | 3,84 | 125,88k | - |
| 2026-02-17 | Mr. Dario ScimecaGeneral Counsel & Secretary | 11,74k | 0,00 | Derivative Exercise and Retained Stock | - | 56,46k | 26,26% |
| 2026-01-20 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 29,15k | 0,00 | Derivative Exercise and Retained Stock | - | 106,45k | 37,71% |
| 2026-01-20 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -15,21k | 61,31k | Derivative Exercise and Sale | 4,03 | 106,45k | - |
| 2026-01-20 | Mr. Dario ScimecaGeneral Counsel & Secretary | 16,46k | 0,00 | Derivative Exercise and Retained Stock | - | 44,72k | 58,24% |
| 2026-01-20 | Mr. Dario ScimecaGeneral Counsel & Secretary | -8,85k | 35,68k | Derivative Exercise and Sale | 4,03 | 44,72k | - |
| 2026-01-20 | Mr. Michael AmorosoPresident, CEO & Director | 80,58k | 0,00 | Derivative Exercise and Retained Stock | - | 196,15k | 69,72% |
| 2026-01-20 | Mr. Michael AmorosoPresident, CEO & Director | -34,80k | 145,11k | Derivative Exercise and Sale | 4,17 | 196,15k | - |
| 2026-01-20 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | 18,97k | 0,00 | Derivative Exercise and Retained Stock | - | 118,12k | 19,13% |
| 2026-01-21 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | -10,20k | 41,11k | Derivative Exercise and Sale | 4,03 | 118,12k | - |
| 2025-12-16 | Mr. Geno J. GermanoIndependent Director | 3,00k | 14,16k | Acquisto | 4,72 | 23,88k | 14,37% |
| 2025-12-15 | Ms. Melinda BrownIndependent Director | 1,38k | 6,86k | Acquisto | 4,97 | 23,35k | 6,29% |
| 2025-12-16 | Dr. Stanley R. FrankelIndependent Director | 2,70k | 12,69k | Acquisto | 4,70 | 19,48k | 16,09% |
| 2025-11-02 | Mr. Dario ScimecaGeneral Counsel & Secretary | 1,17k | 0,00 | Derivative Exercise and Retained Stock | - | 28,26k | 4,32% |
| 2025-11-02 | Mr. Dario ScimecaGeneral Counsel & Secretary | -665,00 | 4,32k | Derivative Exercise and Sale | 6,49 | 28,26k | - |
| 2025-11-02 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 2,30k | 0,00 | Derivative Exercise and Retained Stock | - | 77,30k | 3,07% |
| 2025-11-02 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -1,30k | 8,46k | Derivative Exercise and Sale | 6,49 | 77,30k | - |
| 2025-11-02 | Mr. Michael AmorosoPresident, CEO & Director | 6,04k | 0,00 | Derivative Exercise and Retained Stock | - | 115,58k | 5,51% |
| 2025-11-02 | Mr. Michael AmorosoPresident, CEO & Director | -3,41k | 22,12k | Derivative Exercise and Sale | 6,49 | 115,58k | - |
| 2025-09-26 | Dr. Stanley R. FrankelIndependent Director | 2,70k | 13,42k | Acquisto | 4,97 | 16,78k | 19,18% |
| 2025-09-22 | Ms. Melinda BrownIndependent Director | 1,40k | 6,85k | Acquisto | 4,89 | 21,97k | 6,81% |
| 2025-07-03 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -14,83k | 63,16k | Automatic Disposition | 4,26 | 73,49k | -16,79% |
| 2025-06-25 | Ms. Melinda BrownIndependent Director | 1,68k | 6,96k | Acquisto | 4,14 | 20,57k | 8,91% |
| 2025-06-25 | Mr. Kevin J. BuehlerIndependent Chairman | 5,08k | 21,12k | Acquisto | 4,16 | 28,14k | 22,01% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
